234 related articles for article (PubMed ID: 25887589)
1. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Zhang H; Teng X; Liu Z; Zhang L; Liu Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
[TBL] [Abstract][Full Text] [Related]
2. Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma.
Liu Z; Sun DX; Teng XY; Xu WX; Meng XP; Wang BS
Endocr Pathol; 2012 Dec; 23(4):247-53. PubMed ID: 23070788
[TBL] [Abstract][Full Text] [Related]
3. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma.
Zhang J; Liu Y; Liu Z; Wang XM; Yin DT; Zheng LL; Zhang DY; Lu XB
Int J Med Sci; 2013; 10(5):585-92. PubMed ID: 23533107
[TBL] [Abstract][Full Text] [Related]
4. Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas.
Degl'Innocenti D; Alberti C; Castellano G; Greco A; Miranda C; Pierotti MA; Seregni E; Borrello MG; Canevari S; Tomassetti A
PLoS One; 2010 Sep; 5(9):e12701. PubMed ID: 20877637
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells.
De Santis E; Di Vito M; Perrone GA; Mari E; Osti M; De Antoni E; Coppola L; Tafani M; Carpi A; Russo MA
Biomed Pharmacother; 2013 Feb; 67(1):7-16. PubMed ID: 23089475
[TBL] [Abstract][Full Text] [Related]
7. ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study.
Li QL; Chen FJ; Lai R; Guo ZM; Luo R; Yang AK
Med Oncol; 2012 Sep; 29(3):1409-17. PubMed ID: 21739307
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas.
Bruland O; Fluge Ø; Akslen LA; Eiken HG; Lillehaug JR; Varhaug JE; Knappskog PM
BMC Cancer; 2009 Dec; 9():425. PubMed ID: 19968886
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis.
Wang Z; Zhang H; Zhang P; Li J; Shan Z; Teng W
Med Oncol; 2013; 30(2):577. PubMed ID: 23609190
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
11. Candidate agents for papillary thyroid cancer identified by gene expression analysis.
Zhu W; Li C; Ai Z
Pathol Oncol Res; 2013 Jul; 19(3):597-604. PubMed ID: 23519608
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
[TBL] [Abstract][Full Text] [Related]
13. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175
[TBL] [Abstract][Full Text] [Related]
14. Signalling pathway mediated by CXCR7, an alternative chemokine receptor for stromal-cell derived factor-1α, in AtT20 mouse adrenocorticotrophic hormone-secreting pituitary adenoma cells.
Yoshida D; Nomura R; Teramoto A
J Neuroendocrinol; 2009 May; 21(5):481-8. PubMed ID: 19302186
[TBL] [Abstract][Full Text] [Related]
15. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
16. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
[TBL] [Abstract][Full Text] [Related]
17. Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.
Scarpino S; Duranti E; Giglio S; Di Napoli A; Galafate D; Del Bufalo D; Desideri M; Socciarelli F; Stoppacciaro A; Ruco L
Thyroid; 2013 Sep; 23(9):1127-37. PubMed ID: 23617728
[TBL] [Abstract][Full Text] [Related]
18. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
Xiong Y; Zhang L; Holloway AK; Wu X; Su L; Kebebew E
PLoS One; 2011; 6(10):e24717. PubMed ID: 21998631
[TBL] [Abstract][Full Text] [Related]
19. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma.
Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X
Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.
Ferrario C; Lavagni P; Gariboldi M; Miranda C; Losa M; Cleris L; Formelli F; Pilotti S; Pierotti MA; Greco A
Lab Invest; 2008 May; 88(5):474-81. PubMed ID: 18332874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
